ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2521

Understanding Age as a Risk Factor for Complications After Total Knee Arthroplasty: What Can We Learn from Machine Learning?

Bella Mehta1, Yi Yiyuan2, Chloe Heiting3, Kaylee Ho2, Susan Goodman3, Peter Sculco3, Fei Wang2, Rich Caruana4, Peter cram5 and Said Ibrahim6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Microsoft, Redmond, WA, 5The University of Texas Medical Branch, Galveston, TX, 6Northwell Health, New Hyde Park, NY

Meeting: ACR Convergence 2023

Keywords: Aging, Arthroplasty, Orthopedics, risk assessment, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Rates of total knee arthroplasty (TKA) in the United Stateshave risen, coupled with increasing demand for TKAs in younger patients.1Althoughrates of postoperative complications in TKA have decreased significantly,2 they remaina significant concern for patients and clinicians. In light of these changing trends in TKA use and outcomes, we sought to understand how risk for adverse TKA outcomes changes with age using machine learning algorithms.

Methods: We studied patients undergoing TKA from the Pennsylvania Health Care Cost Containment Council (PHC4) Database, 2012-2018.Our primary variable of interest was age as a risk factor for the binary outcomes of 90-day readmission, 90-day mortality, 1-year revision, and the continuous outcome length of stay (LOS). Our model included patient-level demographics and covariates, including sex, race, discharge location, and insurance. We trained explainable boosting machines (EBMs)to predict risk (70% train:30% test) for the aforementioned outcomes.3For binary outcomes, we stratified the training data by outcome for balance. EBMs are highly accurate, interpretable models that are flexible in visualizing the dependent variables and handle collinearity well which is important in TKA. We report test AUROCs and R2as evaluation metrics for predictive performance of the models, and further include partial dependency plots which explain the relationship of age with these outcomes.

Results: We had a cohort of 227,959TKA patients, with a median age of 65 years with 90.1% White and 55% Medicare-insured (Table 1).90-day readmission was observed in 7.49%, 90-day mortality in 0.22%, and 1-year revision in 0.79%. Predictive performance of adverse outcomes was strongest for 90-day mortality (AUROC=0.74), followed by 1-year revision (AUROC=0.64), 90-day readmission (AUROC=0.62), and LOS (RMSE=0.36, R2=0.13). Age was among the most important factors for predicting all outcomes and its relationship with the outcomes is detailed in the partial dependency plots in Figure 1.Predicted risk of90-day mortality increases significantly after the age of 77.5 years, whereas90-day readmission increases after the age of 73.5 years, and LOS risk increases at 73.5 years. However, with 1-year revision the risk decreases after the age of 63.5 (Figure 1).

Conclusion: We determined that the effect of age as a risk factor for poor TKA outcomes changes dramatically at specific time points, thus demonstrating that there is a nonlinear relationship between age and TKA outcomes. Traditional regression models have always been understood to have a proportionate increase in risk as age increases. However, our study gives nuance to this understanding and can help physicians and patients in decision-making when trying to quantify risks related to aging as they consider TKA as a treatment option.

References

  1. Ravi B et al. The changing demographics of total joint arthroplasty recipients in the United States and Ontario from 2001 to 2007. PMID:23218428
  2. Singh JA et al. Rates of Total Joint Replacement in the United States: Future Projections to 2020–2040 Using the National Inpatient Sample. PMID:30988126
  3. Nori H et al. InterpretML: A Unified Framework for Machine Learning Interpretability. arXiv:1909.09223

Supporting image 1

Table 1: Cohort Characteristics by Outcome

Supporting image 2

Figure 1: Partial dependency plots to understand the marginal effect of age (years) on (A) 90-day mortality, (B) 90-day readmission, (C) 1-year revision, and (D) length of stay from the supervised explainable boosting machine models.
Y-axis score is shown in log scale. Vertical lines demonstrate where risk score is equal to 0, and show the age of the average contribution to risk.


Disclosures: B. Mehta: Janssen, 1, Novartis, 5; Y. Yiyuan: None; C. Heiting: None; K. Ho: None; S. Goodman: NIH, 5, Novartis, 5; P. Sculco: DePuy Synthes, 2, EOS Imaging, 2, Intellijoint Surgical, 2, 5, Lima Corporate, 2, Zimmer Biomet, 2, 5; F. Wang: None; R. Caruana: None; P. cram: None; S. Ibrahim: None.

To cite this abstract in AMA style:

Mehta B, Yiyuan Y, Heiting C, Ho K, Goodman S, Sculco P, Wang F, Caruana R, cram P, Ibrahim S. Understanding Age as a Risk Factor for Complications After Total Knee Arthroplasty: What Can We Learn from Machine Learning? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/understanding-age-as-a-risk-factor-for-complications-after-total-knee-arthroplasty-what-can-we-learn-from-machine-learning/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-age-as-a-risk-factor-for-complications-after-total-knee-arthroplasty-what-can-we-learn-from-machine-learning/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology